Interleukin-8 and hIRH (SDF1-α/PBSF) mRNA expression and histological activity index in patients with chronic hepatitis C

Hepatology

Volumn 28, Issue 1, 1998, Pages 108-115

  Shimoda, Katsuhiro ^a   Begum, Nasim Ara ^a   Shibuta, Kenji ^a   Mori, Masaki ^b   Bonkovsky, Herbert L ^a   Banner, Barbara F ^a   Barnard, Graham F ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b KYUSHU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; CHEMOKINE RECEPTOR; INTERLEUKIN 8; MESSENGER RNA; RECOMBINANT HUMAN INTERCRINE REDUCED IN HEPATOMAS; STROMAL CELL DERIVED FACTOR 1; UNCLASSIFIED DRUG;

ARTICLE; BILE DUCT INJURY; CHRONIC HEPATITIS; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; HEPATITIS C; HUMAN; HUMAN TISSUE; INFLAMMATION; MESSENGER RNA SYNTHESIS; NEUTROPHIL CHEMOTAXIS; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALS; CHEMOKINES, CXC; CHEMOTACTIC FACTORS; CHEMOTAXIS, LEUKOCYTE; HEPATITIS C, CHRONIC; HEPATITIS, ANIMAL; HUMANS; INTERLEUKIN-8; NEUTROPHILS; RATS; RECOMBINANT PROTEINS; RNA, MESSENGER;

EID: 0031807539     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.510280116     Document Type: Article

References (33)

1. Taub DD, Oppenheim JJ. Chemokines, inflammation, and the immune system. Ther Immunol 1994;1:229-246.
2. Begum NA, Coker A, Shibuta K, Swanson RS, Chen LB, Mori M, Barnard GE Loss of hIRH mRNA expression from premalignant adenomas and malignant cell lines. Biochem Biophys Res Commun 1996;229:864-868.
3. Shibuta K, Begum NA, Mori M, Shimoda K, Akiyoshi T, Barnard GE Reduced expression of hIRH/SDFl α/PBSF in gastrointestinal tract cancers. Int J Cancer 1997;73:656-662.
4. Shirozu M, Nakano T, Inazawa J, Tashiro K, Tada H, Shinohara T, Honjo T. Structure and chromosomal localization of the human stromal cell-derived factor 1 (SDF1) gene. Genomics 1995;28:495-500.
5. Nomura M, Matsuda Y, Itoh H, Hori T, Suzuki G. Genetic mapping of the mouse stromal cell-derived factor gene (Sdfl) to mouse and rat chromosomes. Cytogenet Cell Genet 1996;73:286-289.
6. Nagasawa T, Hirota S, Tachibana K, Takakura N, Nishikawa S, Kitamura Y, Yoshida N, et al. Defects of B-cell lymphopoiesis and bone-marrow myelopoiesis in mice lacking the CXC chemokine PBSF/SDF-1. Nature 1996;382:635-638.
7. Oberlin E, Amara A, Bachelerie F, Bessia C, Virelizier J-L, Arenzana-Seisdedos F, Schwartz O, et al. The CXC chemokine SDF-1 is the ligand for LESTR/fusin and prevents infection by T-cell-line-adapted HIV-1. Nature 1996;382:833-835.
8. Bleul CC, Fuhlbrigge RC, Casasnovas JM, Aiuti A, Springer TA. A highly efficacious lymphocyte chemoattractant, stromal cell-derived factor 1 (SDF-1). J Exp Med 1996;184:1101-1109.
9. Oppenheim JJ, Zachariae COC, Mukaida N, Matsushima K. Properties of the novel proinflammatory supergene "inlercrine" cytokine family. Annu Rev Immunol 1991;9:617-641.
10. Baggiolini M, Dewald B, Moser B. Interleukin-8 and related chemotactic cytokines - CXC and CC chemokines. Adv Immunol 1994;55:97-179.
11. Isaacs KL, Sartor RB, Haskill S. Cytokine messenger RNA profiles in inflammatory bowel disease mucosa detected by polymerase chain reaction amplification. Gastroenterology 1992;103:1587-1595.
12. Mazzucchelli L, Hauser C, Zgraggen K, Wagner H, Hess M, Laissue JA, Muller C. Expression of interleukin-8 gene in inflammatory bowel disease is related to the histological grade of active inflammation. Am J Pathol 1994;144:997-1007.
13. al-Wabel A, al-Knawy B, Raziuddin S. Interleukin-8 and granulocyte-macrophage colony-stimulating factor secretion in hepatocellular carcinoma and viral chronic active hepatitis. Clin Immunol Immunopathol 1995;74:231-235.
14. Hill DB. Increased plasma interleukin-8 concentrations in alcoholic hepatitis. HEPATOLOGY 1993;18:576-580.
15. Maggiore G, De Benedetti F, Massa M, Pignatti P, Martini A. Circulating levels of interleukin-6, interleukin-8, and tumor necrosis factor-alpha in children with autoimmune hepatitis. J Pediatr Gastroenterol Nutr 1995;20:23-27.
16. Napoli J, Bishop GA, McCaughan GW. Increased intrahepatic messenger RNA expression of interleukin 2, 6, and 8 in human cirrhosis. Gastroenterology 1994;107:789-798.
17. Sheron N, Bird G, Koskinas J, Portmann B, Ceska M, Lindley I. Circulating and tissue levels of the neutrophil chemotaxin interleukin-8 are elevated in severe acute alcoholic hepatitis, and tissue levels correlate with neutrophil infiltration. HEPATOLOGY 1993;18:41-46.
18. Tashiro K, Tada H, Heilker R, Shirozu M, Nakano T, Honjo T. Signal sequence trap: a cloning strategy for secreted proteins and type I membrane proteins. Science 1993;261:600-603.
19. Sambrook J, Fritsch E, Maniatis T. Molecular Cloning: A Laboratory Manual. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory, 1989.
20. Frangioni JV, Neel BJ. Solubilization and purification of enzymatically active glutathione S-transferase (pGEX) fusion proteins. Anal Biochern 1993;210:179-187.
21. Hunkapiller MW, Lujan E, Ostrander F, Hood LE: Isolation of microgram quantities of proteins from polyacrylamide gels for amino acid sequence analysis. In: Hirs CHW, Timasheff SN, eds. Methods Enzymol. New York: Academic Press, 1983:227-236.
22. Lackmann M, Rajesekariah P, lismaa SE, Jones G, Cornish CJ, Hu S, Simpson RJ. Identification of a chemotactic domain of the proinflammatory S100 protein CP-10.J Immunol 1993;150:2981-2991.
23. Zagorski J, DeLarco JE. Expression of active human Gro beta and Gro gamma neutrophil chemotactic proteins in E. coli. Protein Expression and Purification 1994;5:337-345.
24. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987;162:156-159.
25. Mon M, Inoue H, Shiraishi T, Mimori K, Shibuta K, Nakashima H, Mafune K, et al. Relaxation of insulin-like growth factor 2 gene imprinting in esophageal cancer. Int J Cancer 1996;68:441-446.
26. Harris PR, Mobley HLT, Perez-Perez GI, Blaser MJ, Smith PD. Helicobacter pylori urease is a potent stimulus of mononuclear phagocyte activation and inflammatory cytokine production. Gastroenterology 1996;111:419-425.
27. Knodell RG, Ishak KG, Black WC, Chen TS, Craig R, Kaplowitz N, Kiernan TW, et al. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. HEPATOLOGY 1981;1:431-435.
28. Calleja JL, Alibillos A, Cacho G, Iborra J, Abreu L, Escartin P. Interferon and prednisone therapy in chronic hepatitis C with non-organ-specific antibodies.J Hepatol 1996;24:308-312.
29. Farinati F, Cardin R, D'Errico A, De Maria R, Naccarato R, Cecchetto A, Grigioni W. Hepatocyte proliferative activity in chronic liver damage as assessed by the monoclonal antibody MIB1 Ki67 in archival material: the role of etiology, disease activity, iron, and Iipid peroxidation. HEPATOLOGY 1996;23:1468-1475.
30. Napoli J, Bishop GA, McGuinness PH, Painter DM, McCaughan GW. Progressive liver injury in chronic hepatitis C infection correlates with increased intrahepatic expression of Th1-associated cytokines. HEPATOLOGY 1996;24:759-765.
31. Gusella GL, Musso T, Basco MC, Espinoza-Delgado I, Matsushima K, Varesio L. IL-2 up-regulates but IFN-g suppresses IL-8 expression in human monocytes. J Immunol 1993;151:2725-2732.
32. Thornton AJ, Stricter RM, Lindley I, Baggiolini M, Kunkel SL. Cytokine-induced gene expression of a neutrophil chemotactic factor/IL-8 in human hepatocytes. J Immunol 1990;144:2609-2613.
33. Strieter RM, Polverini PJ, Kunkel SL, Arenberg DA, Burdick MD, Kasper J, Dzuiba J, et al. The functional role of the ELR motif in CXC chemokine-mediated angiogenesis. J Biol Chem 1995;270:27348-27357.